Måndag 30 December | 18:13:04 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2026-02-26 08:30 Bokslutskommuniké 2025
2025-11-28 08:30 Kvartalsrapport 2025-Q3
2025-08-28 08:30 Kvartalsrapport 2025-Q2
2025-06-18 N/A Årsstämma
2025-05-22 08:30 Kvartalsrapport 2025-Q1
2025-02-27 08:30 Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-27 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-06 - Extra Bolagsstämma 2024
2024-03-05 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-19 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-31 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 - Årsstämma
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-27 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 - Årsstämma
2017-05-31 - Kvartalsrapport 2017-Q1
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-24 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-25 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 - Årsstämma
2015-05-25 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-24 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-05-22 - Årsstämma
2014-05-22 - Kvartalsrapport 2014-Q1
2014-02-28 - Bokslutskommuniké 2013
2013-11-29 - Kvartalsrapport 2013-Q3
2013-08-26 - Kvartalsrapport 2013-Q2
2013-06-28 - Split AXIC A 4:1
2013-05-30 - Kvartalsrapport 2013-Q1
2013-05-21 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 - Årsstämma
2013-02-28 - Bokslutskommuniké 2012
2012-11-26 - Kvartalsrapport 2012-Q3
2012-08-30 - Kvartalsrapport 2012-Q2
2012-05-28 - Kvartalsrapport 2012-Q1
2012-05-17 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-28 - Kvartalsrapport 2011-Q3
2011-08-30 - Kvartalsrapport 2011-Q2
2011-05-30 - Kvartalsrapport 2011-Q1
2011-05-10 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 - Årsstämma
2011-02-25 - Bokslutskommuniké 2010
2010-05-11 - X-dag ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar framförallt med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontoret i Malmö.
2024-06-25 08:30:00

aXichem AB (publ), (https://www.axichem.com/) (aXichem) a pioneer of innovative natural analogue ingredients for the nutraceutical industry, is pleased to announce a significant new order from its U.S. distributor SEE Nutrition (https://see-nutrition.com/). The order, valued at SEK 3 million, is for one metric ton of aXivite (https://axivite.com/) a scientifically proven synthetic capsaicin ingredient. SEE Nutrition markets and sells aXivite to suppliers of sports, fitness, pre-workout and weight management nutrition products and supplements in the U.S. Market.

"SEE Nutrition reports robust sales growth of aXivite from both new and existing customers. This order ensures that they can maintain short lead times for their clients. aXivite is gaining considerable attention due to its documented effects on sports performance and training and new consumer products are continuously being developed and tested. I am delighted that SEE Nutrition is proactively positioning aXivite as a safe, effective, and versatile ingredient in this rapidly growing market segment", says Lucas Altepost, VP Sales & Marketing at aXichem.

The global sports nutrition market continues to show robust growth, driven by increasing consumer interest in health, fitness, and performance. According to the Nutrition Business Journal, U.S. sports nutrition and weight management sales are expected to reach $102.32 billion by 2027, up from $69.86 billion in 2023. This growth is largely attributed to the increasing popularity of sports nutrition supplements, protein beverages, and weight management products.

About phenylcapsaicin and aXivite
aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capsaicin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.

The information was submitted, through the care of the contact person below, for publication on 25 June 2024, at 08:30 AM CET.

Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: torsten.helsing@axichem.com

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen[®] and aXivite[®], as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio- enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.

More information is available at www.axichem.com.